Skip to content

Effectiveness of Acupuncture for Asthma

Effectiveness of Acupuncture for Asthma: A Randomized, Sham-acupuncture and Waiting-list Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00917215
Enrollment
45
Registered
2009-06-10
Start date
2008-09-30
Completion date
2009-04-30
Last updated
2009-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Acupuncture, Pulmonary function, Quality of life

Brief summary

What is the trend of changes in asthmatic patients' daily peak expiratory flow (PEF) variability, pulmonary function, and quality of life (QOL) with acupuncture treatment on specific acupoints (CV22 and bilateral LU5, ST40, BL13, EXB1) compared with minimal acupuncture treatment (sham control group) on non-acupoints, and no acupuncture treatment (waiting list control group)?

Interventions

DEVICEDisposable stainless steel acupuncture (0.2mmx4mm)

For active acupuncture group, needles were inserted into nine acupoints (CV22 and bilateral LU5, ST40, BL13, EXB1)with De-qi three times a week for 4 weeks. For sham acupuncture group, Nine non-acupoints corresponded with each active acupoint were treated with minimal penetration into skin three times a week for 4 weeks.

Sponsors

Korea Institute of Oriental Medicine
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* aged 19-70 years * at least 12% improvement in forced expiratory volume in one second (FEV1)after the administration of short acting beta2 agonist. * at least one typical asthmatic symptom * using more than one routine anti-asthmatic medicine

Exclusion criteria

* acupuncture for asthma within 12 months of the study * emergency department visit within one month of the study * hospitalization for asthma within three months of the study * severe upper respiratory tract infections within six weeks of the study * systemic infections, cancers, autoimmune disorders, cardiac failures, myofacial infarcts,angina pectoris, renal failures or hepato-biliary diseases * smoke more than ten cigarettes per day

Design outcomes

Primary

MeasureTime frame
Change of weekly average of peak expiratory flow (PEF)values in the morning at homeFrom 1 week of run-in period to the 4th week of treatment

Secondary

MeasureTime frame
Forced expiratory volume in 1 second (FEV1) Baseline Dyspnea Index (BDI) Transition Dyspnea Index (TDI) Quality of Life Questionnaire for Adult Korean Asthmatics (QLQAKA)Baseline and 2 weeks, 4 weeks, 6 weeks after Baseline (BDI for baseline only, TDI for 2, 4, and 6 weeks after baseline)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026